Effects of SMG1 inhibition were tested in in vivo models, using CC‐115 as it has already been tested in humans in advanced solid and hematologic malignancies [15], and SMGi compound cannot be applied in vivo. This evidence concerns the gene SMG1 and hematologic disorder.